Pacira BioSciences Statistics

Total Valuation

PCRX has a market cap or net worth of $1.13 billion. The enterprise value is $1.31 billion.

Market Cap	1.13B
Enterprise Value	1.31B

Important Dates

The last earnings date was Tuesday, August 5, 2025, after market close.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

PCRX has 44.93 million shares outstanding. The number of shares has decreased by -15.61% in one year.

Current Share Class	44.93M
Shares Outstanding	44.93M
Shares Change (YoY)	-15.61%
Shares Change (QoQ)	-2.29%
Owned by Insiders (%)	0.99%
Owned by Institutions (%)	112.62%
Float	42.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	8.40
PS Ratio	1.63
Forward PS	1.92
PB Ratio	1.48
P/TBV Ratio	3.57
P/FCF Ratio	9.61
P/OCF Ratio	8.36
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.27, with an EV/FCF ratio of 11.20.

EV / Earnings	n/a
EV / Sales	1.86
EV / EBITDA	8.27
EV / EBIT	19.15
EV / FCF	11.20

Financial Position

The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.83.

Current Ratio	2.38
Quick Ratio	1.79
Debt / Equity	0.83
Debt / EBITDA	3.63
Debt / FCF	5.39
Interest Coverage	3.67

Financial Efficiency

Return on equity (ROE) is -15.57% and return on invested capital (ROIC) is 2.93%.

Return on Equity (ROE)	-15.57%
Return on Assets (ROA)	2.69%
Return on Invested Capital (ROIC)	2.93%
Return on Capital Employed (ROCE)	5.59%
Revenue Per Employee	$893,478
Profits Per Employee	-$161,342
Employee Count	790
Asset Turnover	0.44
Inventory Turnover	1.88

Taxes

In the past 12 months, PCRX has paid $20.91 million in taxes.

Income Tax	20.91M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +103.38% in the last 52 weeks. The beta is 0.48, so PCRX's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	+103.38%
50-Day Moving Average	23.62
200-Day Moving Average	22.77
Relative Strength Index (RSI)	62.71
Average Volume (20 Days)	766,694

Short Selling Information

The latest short interest is 5.69 million, so 12.67% of the outstanding shares have been sold short.

Short Interest	5.69M
Short Previous Month	5.46M
Short % of Shares Out	12.67%
Short % of Float	13.49%
Short Ratio (days to cover)	9.86

Income Statement

In the last 12 months, PCRX had revenue of $705.85 million and -$127.46 million in losses. Loss per share was -$2.81.

Revenue	705.85M
Gross Profit	469.43M
Operating Income	68.44M
Pretax Income	100.55M
Net Income	-127.46M
EBITDA	158.43M
EBIT	68.44M
Loss Per Share	-$2.81

Full Income Statement

Balance Sheet

The company has $445.86 million in cash and $631.40 million in debt, giving a net cash position of -$185.54 million or -$4.13 per share.

Cash & Cash Equivalents	445.86M
Total Debt	631.40M
Net Cash	-185.54M
Net Cash Per Share	-$4.13
Equity (Book Value)	757.77M
Book Value Per Share	16.88
Working Capital	432.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $134.52 million and capital expenditures -$17.46 million, giving a free cash flow of $117.07 million.

Operating Cash Flow	134.52M
Capital Expenditures	-17.46M
Free Cash Flow	117.07M
FCF Per Share	$2.61

Full Cash Flow Statement

Margins

Gross margin is 66.51%, with operating and profit margins of 9.70% and -18.06%.

Gross Margin	66.51%
Operating Margin	9.70%
Pretax Margin	-15.10%
Profit Margin	-18.06%
EBITDA Margin	22.45%
EBIT Margin	9.70%
FCF Margin	16.59%

Dividends & Yields

PCRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	15.61%
Shareholder Yield	15.61%
Earnings Yield	-11.33%
FCF Yield	10.40%

Dividend Details

Analyst Forecast

The average price target for PCRX is $27.14, which is 8.76% higher than the current price. The consensus rating is "Buy".

Price Target	$27.14
Price Target Difference	8.76%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	7.39%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PCRX has an Altman Z-Score of 1.5 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.5
Piotroski F-Score	6